PW Medtech Group Limited

HKEX:1358.HK

1.05 (HKD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q22017 Q22016 Q42016 Q22015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q32012 Q22012 Q12011 Q4
Revenue 338.417356.069319.015322.577214.249137.907133.492145.816101.536189.874172.309142.993130.27655.052264.531325.407339.88268.179238.333218.75114.27182.88582.88582.88582.885
Cost of Revenue 150.796151.971142.216144.84393.15854.33151.01256.72542.02374.32565.73155.19549.39240.83868.43978.90587.66377.50775.29671.3636.66428.17428.17428.17428.174
Gross Profit 187.621204.098176.799177.734121.09183.57682.4889.09159.513115.549106.57887.79880.88414.214196.092246.502252.217190.672163.037147.3977.60754.71254.71254.71254.712
Gross Profit Ratio 0.5540.5730.5540.5510.5650.6060.6180.6110.5860.6090.6190.6140.6210.2580.7410.7580.7420.7110.6840.6740.6790.660.660.660.66
Reseach & Development Expenses 20.59718.15622.97427.28313.69212.8877.36637.50110.69418.1619.78112.2295.1882.229.49316.40733.05113.99919.8766.6145.8032.3782.3782.3782.378
General & Administrative Expenses 60.27159.22259.79884.92137.17734.39126.91923.43433.11134.44230.79811.89725.6411.85132.6451.20522.71756.48326.02533.27228.1198.9018.9018.9018.901
Selling & Marketing Expenses 39.91936.86639.2231.62735.84427.72634.05336.14846.52250.93150.22631.58624.7328.1133.58642.78465.57128.65333.428.54215.48611.70511.70511.70511.705
SG&A 100.1996.08899.018116.54873.02158.02465.06563.00985.97796.06785.82743.48350.37220.7366.22693.98989.08785.13659.72561.81443.60520.60620.60620.60620.606
Other Expenses -17.677-9.3920000000000000000-1.437-1.429-1.429-1.179-1.179-1.179-1.179
Operating Expenses 103.11104.85288.649121.52254.46137.795652.473398.684.52178.20629.61542.73849.82513.87770.829107.842142.3595.701128.16768.17747.97821.80621.80621.80621.806
Operating Income 84.51199.24685.8347.93850.22924.88922.179-3.058-21.6321.35919.50236.00231.059-7.041124.567138.637144.81694.97192.52679.87826.44716.17716.17716.17716.177
Operating Income Ratio 0.250.2790.2690.1490.2340.180.166-0.021-0.2130.1120.1130.2520.238-0.1280.4710.4260.4260.3540.3880.3650.2310.1950.1950.1950.195
Total Other Income Expenses Net 27.7923.41322.57821.74113.163-53.26930.891494.474156.81331.44852.6899.8791.1222.4432.4711.839-9.557.1150.355-5.5342.01913.75413.75413.75413.754
Income Before Tax 112.301122.659108.40877.95379.794-28.38765.844491.416135.18323.50762.30145.88132.1810.805127.038140.476109.236102.08639.51974.34428.46629.9329.9329.9329.93
Income Before Tax Ratio 0.3320.3440.340.2420.372-0.2065.7373.371.3310.1240.3620.3210.2470.0150.480.4320.3210.3810.1660.340.2490.3610.3610.3610.361
Income Tax Expense 18.66214.50911.53520.5718.3096.4084.7550.7565.9681.3982.4417.2256.5430.22519.98525.26116.68918.0038.75614.1045.7154.8854.8854.8854.885
Net Income 70.21982.20870.97645.41360.628-21.971761.091490.661141.15322.11359.86938.34715.8421.138107.998115.21592.54784.08327.89150.01422.75125.04625.04625.04625.046
Net Income Ratio 0.2070.2310.2220.1410.283-0.1595.7013.3651.390.1160.3470.2680.1220.0210.4080.3540.2720.3140.1170.2290.1990.3020.3020.3020.302
EPS 0.0450.0530.0450.0290.039-0.0140.490.310.090.0140.0380.0240.010.0010.0650.0670.0540.0490.020.0430.0180.0150.0150.0150.015
EPS Diluted 0.0450.0530.0450.0290.039-0.0140.490.310.090.0140.0380.0240.010.0010.0650.0670.0540.0490.020.0430.0180.0150.0150.0150.015
EBITDA 131.006153.925122.1894.43681.05440.53537.4459.005-6.06336.26233.00947.08853.119-9.295146.448168.398169.953108.003103.66189.15331.77820.6620.6620.6620.66
EBITDA Ratio 0.3870.4320.4230.2930.3780.2940.2810.062-0.060.1910.1920.3290.408-0.1690.5540.5170.50.4030.4350.4080.2780.2490.2490.2490.249